| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
24,685 |
20,817 |
$2.13M |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
4,161 |
3,483 |
$1.43M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
23,301 |
19,688 |
$1.40M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
7,856 |
7,165 |
$664K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
16,407 |
15,005 |
$599K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
5,843 |
5,310 |
$480K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
5,329 |
1,150 |
$304K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
3,527 |
3,250 |
$296K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
17,225 |
15,446 |
$250K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
3,037 |
2,343 |
$81K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,154 |
1,084 |
$53K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
551 |
520 |
$50K |
| 99174 |
|
1,980 |
1,883 |
$25K |
| 90670 |
|
2,927 |
2,836 |
$25K |
| 92551 |
|
1,421 |
1,345 |
$15K |
| 90461 |
|
8,966 |
8,182 |
$14K |
| 96127 |
|
1,107 |
1,040 |
$14K |
| 99177 |
|
833 |
809 |
$12K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
1,059 |
1,005 |
$12K |
| 83655 |
|
910 |
864 |
$11K |
| 99215 |
Prolong outpt/office vis |
67 |
62 |
$8K |
| 85018 |
|
3,699 |
3,288 |
$8K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
87 |
83 |
$7K |
| 90686 |
|
2,420 |
2,262 |
$7K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
188 |
173 |
$7K |
| 90698 |
|
1,779 |
1,727 |
$7K |
| 0072A |
|
112 |
102 |
$6K |
| 0071A |
|
124 |
101 |
$6K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
428 |
226 |
$6K |
| 90677 |
|
417 |
319 |
$6K |
| 99381 |
|
60 |
56 |
$6K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
391 |
378 |
$6K |
| 80061 |
Lipid panel |
415 |
386 |
$5K |
| 36416 |
|
4,092 |
3,668 |
$4K |
| 90680 |
|
1,344 |
1,304 |
$4K |
| 90651 |
|
101 |
94 |
$4K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
43 |
40 |
$3K |
| 99173 |
|
597 |
563 |
$3K |
| H0049 |
Alcohol and/or drug screening |
298 |
289 |
$3K |
| 99382 |
|
32 |
27 |
$3K |
| 90633 |
|
767 |
725 |
$3K |
| 99383 |
|
22 |
22 |
$2K |
| 90480 |
|
43 |
40 |
$2K |
| 90697 |
|
499 |
436 |
$2K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,009 |
942 |
$2K |
| D0145 |
Oral evaluation for a patient under three years of age |
49 |
48 |
$1K |
| 90619 |
|
33 |
28 |
$1K |
| 94760 |
|
406 |
368 |
$971.70 |
| 90710 |
|
15 |
13 |
$942.72 |
| 90656 |
|
438 |
429 |
$918.05 |
| 90672 |
|
253 |
240 |
$905.70 |
| D0190 |
|
60 |
60 |
$858.28 |
| D1206 |
Topical application of fluoride varnish |
42 |
39 |
$639.60 |
| 99050 |
|
77 |
72 |
$555.88 |
| 96380 |
|
23 |
22 |
$460.84 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
37 |
37 |
$426.32 |
| 90688 |
|
942 |
925 |
$399.11 |
| 90744 |
|
386 |
375 |
$314.49 |
| 91321 |
|
24 |
22 |
$273.00 |
| 90696 |
|
15 |
13 |
$211.98 |
| 90707 |
|
43 |
43 |
$179.20 |
| 88720 |
|
44 |
26 |
$172.68 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
14 |
13 |
$172.37 |
| 90734 |
|
13 |
13 |
$146.62 |
| 87807 |
|
12 |
12 |
$129.25 |
| 90660 |
|
12 |
12 |
$115.98 |
| 90715 |
|
41 |
41 |
$102.20 |
| 90716 |
|
34 |
33 |
$54.50 |
| 36415 |
Collection of venous blood by venipuncture |
12 |
12 |
$30.00 |
| 90685 |
|
290 |
283 |
$22.96 |
| 90658 |
|
26 |
26 |
$11.50 |
| 81003 |
|
25 |
25 |
$8.31 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
15 |
15 |
$3.60 |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
37 |
37 |
$0.73 |
| 91307 |
|
256 |
205 |
$0.00 |